Table 2.
Comparison of laboratory findings in both groups.
| Diabetics (n = 102) | Controls (n = 103) | p | |
|---|---|---|---|
| Serum creatinine (μmol/L)$ | 91 (74–102) | 84 (69–98) | 0.03 |
| Serum urea (mmol/L)$ | 4.6 (3.5–5.1) | 3.7 (2.6–4.9) | 0.003 |
| Hemoglobin (g/dL)$ | 13.8 (13–14.8) | 14.2 (13.6–14.8) | 0.14 |
| Serum uric acid (mmol/L)∗∗ | 5.6 ± 1.5 | 5.0 ± 1.5 | 0.01 |
| Random plasma glucose (mmol/L)∗∗ | 12.0 ± 3.9 | 6.0 ± 1.6 | <0.001 |
| Glycated hemoglobin (%)$ | 7.1 (5.3–8.1) | 4.6 (3.9–5.2) | <0.001 |
| Total cholesterol (mg/dL)∗∗ | 5.0 ± 1.4 | 3.5 ± 1.3 | <0.001 |
| Triglycerides (mg/dL)∗∗ | 2.13 ± 0.93 | 1.40 ± 0.81 | <0.001 |
| LDL-cholesterol (mg/dL)$ | 3.0 (1.4–3.9) | 1.4 (1.02–1.7) | <0.001 |
| HDL-cholesterol (mg/dL)$ | 1.1 (0.86–1.2) | 0.98 (0.86–1.2) | 0.83 |
| Atherogenic ratio (total cholesterol/HDL)$ | 4.4 (3.2–6.9) | 3.3 (2.4–4.6) | <0.001 |
| UAC (mg/L)$ | 23 (10–100) | 0.36 (0.3–10.2) | <0.001 |
| Estimated GFRCG (mL/min)$ | 68 (54–87) | 81 (58–104) | 0.02 |
| Estimated GFRMDRD (mL/min/1.73 m2)$ | 82.7 (67.1–97.9) | 88.7 (76.2–117.8) | 0.01 |
| Estimated GFRCKD-EPI (mL/min/1.73 m2)$ | 82.5 (67.4–97.3) | 90.0 (75.7–109.8) | 0.004 |
| Urinary β2m (μg/mL)$ | 0.41 (0.1–0.99) | 0.1 (0.1–0.41) | 0.002 |
UAC: urinary albumin concentration; β2m: beta-2-microglobulin. ∗∗Mean (SD). $Median (IQR).